Please login to the form below

Not currently logged in
Email:
Password:

ProPharma selects new CEO and president

Dawn Sherman takes up the roles effective 14 May

ProPharma Group has appointed a new chief executive officer and president in the form of Dawn Sherman.

Sherman brings extensive international strategy and experience to the group following multiple executive leadership positions.

Most recently, Sherman was president of EnvisionRxOptions, a role where she was responsible for the pharmacy benefit management and technology company lines of business.

She has also held the role of chief operating officer for Teva Pharmaceuticals, where her focus included strategy and innovation for patient solutions, commercial effectiveness, market access, business insights and market intelligence.

Sherman said: “It is an honour to join ProPharma Group and the great people that have contributed to the company’s success.

“I am incredibly excited about the many opportunities that lie ahead for this dynamic, growing business.

Sherman succeeds Jeff Hargroves, founder and CEO of ProPharma group, who will continue to be an active member of the board.

1st May 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics